Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III repeated intermittent ulipristal acetate treatment in women with uterine fibroids and heavy uterine bleeding
2010-019497-32Phase 3Completed
- Sponsor
- PregLem
- Start
- Jul 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Fibromyoma (LM) comparing Ulipristal acetate followed by norethisterone acetate with Ulipristal acetate followed by placebo (2 arms). Primary endpoint: Sustained efficacy on myoma symptoms, specifically uterine bleeding. Started Jul 2010; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2010-019497-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019497-32.